SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-168460
Filing Date
2023-06-16
Accepted
2023-06-16 07:15:52
Documents
18
Period of Report
2023-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481795d8k.htm   iXBRL 8-K 36630
2 EX-1.1 d481795dex11.htm EX-1.1 188874
3 EX-4.1 d481795dex41.htm EX-4.1 81729
4 EX-5.1 d481795dex51.htm EX-5.1 8148
5 EX-99.1 d481795dex991.htm EX-99.1 9800
6 EX-99.2 d481795dex992.htm EX-99.2 10372
10 GRAPHIC g481795g0615201141370.jpg GRAPHIC 5342
  Complete submission text file 0001193125-23-168460.txt   559115

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA iron-20230612.xsd EX-101.SCH 2865
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20230612_lab.xml EX-101.LAB 18737
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20230612_pre.xml EX-101.PRE 11717
12 EXTRACTED XBRL INSTANCE DOCUMENT d481795d8k_htm.xml XML 3466
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 231019353
SIC: 2834 Pharmaceutical Preparations